Seelos Therapeutics Inc Net Income per Employee (SEEL), current and historic results, rankings and more, Quarterly Fundamentals - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Seelos Therapeutics inc   (NASDAQ: SEEL)
 

Seelos Therapeutics Inc Net Income per Employee

SEEL's Quarterly Results, Trends, Rankings, Statistics
Seelos Therapeutics Inc 's Income per employee grew in the second quarter 2024 on a trailing twelve month basis to $ 255,687, the income was higher than average, indicating higher productivity of the company's employees.
The Healthcare sector has seen employees of 26 other companies achieving higher income per employee. While Seelos Therapeutics Inc 's total ranking has deteriorated compared to the previous quarter from 0 to 416.


What is Income per Employee Ratio?





Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

SEEL Net Income per Employee (Jun 30 2024)
II. Quarter		 (Mar 31 2024)
I. Quarter		 (Dec 31 2023)
IV. Quarter		 (Sep 30 2023)
III. Quarter		 (Jun 30 2023)
II. Quarter
Y / Y Net Income Change - - - - -
Net Income per Employee (TTM) $ 255,688 -1,694,688 -2,367,625 -3,192,875 -5,074,250
SEEL's Total Ranking # 416 # 0 # 0 # 0 # 0
Seq. Net Income Change - - - - -

SEEL Company Profile >> Back to SEEL Efficiency Comparisons >> Compare SEEL Net Income per Employee to its Competitors

SEEL Net Income per Employee Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 27
Healthcare Sector # 38
Overall Market # 416

Net Income per Employee Statistics
High Average Low
$ 353,125 $ -1,940,048 $ -5,133,500
(Jun 30 2017)   (Sep 30 2022)







Companies with similar Income per Employee for 12 month ending Jun 30 2024, within Healthcare Sector Income per Employee Income 12 month ending Jun 30 2024Number of Employees Jun 30 2024
Zura Bio Limited  437,925.00 $ 17.517  Million 40 
Harmony Biosciences Holdings inc   392,467.58 $ 114.993  Million 293 
Orgenesis Inc   385,961.04 $ 29.719  Million 77 
Catalyst Pharmaceuticals Inc   374,445.05 $ 68.149  Million 182 
Lantheus Holdings Inc   359,158.42 $ 428.476  Million 1,193 
Krystal Biotech Inc   359,115.25 $ 105.939  Million 295 
Dariohealth Corp   307,890.91 $ 50.802  Million 165 
Elite Pharmaceuticals Inc   301,270.69 $ 19.583  Million 65 
Regeneron Pharmaceuticals Inc   280,447.76 $ 4,321.700  Million 15,410 
Johnson and Johnson  270,014.20 $ 38,018.000  Million 140,800 
Seelos Therapeutics inc   255,687.50 $ 4.091  Million 16 
Precision Biosciences Inc  249,544.12 $ 16.969  Million 68 
Kiora Pharmaceuticals Inc   246,154.92 $ 3.200  Million 13 
Amgen Inc   240,769.23 $ 3,130.000  Million 13,000 
Collegium Pharmaceutical Inc   236,153.66 $ 99.893  Million 423 
Carlisle Companies Incorporated  233,186.44 $ 1,375.800  Million 5,900 
Entera Bio Ltd   193,000.00 $ 4.246  Million 22 
Tevogen Bio Holdings Inc   184,656.56 $ 3.324  Million 18 
Merck and Co Inc   183,360.00 $ 13,752.000  Million 75,000 
Sharps Technology Inc   182,565.21 $ 5.294  Million 29 
Corcept Therapeutics Inc  171,187.67 $ 124.967  Million 730 
Neurocrine Biosciences Inc   169,600.00 $ 339.200  Million 2,000 
Zoetis Inc   161,517.24 $ 2,342.000  Million 14,500 
Cytomx Therapeutics Inc   160,666.67 $ 11.086  Million 69 
Tg Therapeutics Inc   156,621.55 $ 62.492  Million 399 
Black Hawk Acquisition Corporation  155,468.00 $ 0.311  Million 2 
Biogen Inc   154,346.67 $ 1,157.600  Million 7,500 
Eli Lilly And Company  146,844.00 $ 7,342.200  Million 50,000 
Alkermes Plc   140,840.49 $ 288.723  Million 2,050 
Jazz Pharmaceuticals Plc  136,651.90 $ 394.924  Million 2,890 


Date modified: 2026-06-22T14:32:38+00:00




Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.